Physician profile
Sandra Mcgill
NPI 1689397515
$403.09
in general payments reported to CMS, 2019-2025
11 companies · $61.76 in 2025
The $61.76 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $240 · 2024: $101 · 2025: $61.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $75.49 | 2023-2024 | Briviact |
| Alexion Pharmaceuticals, INC. | $71.23 | 2023-2025 | Koselugo |
| Ns Pharma, INC. | $49.12 | 2023 | Viltepso |
| Karl Storz Endoscopy-America | $37.04 | 2023 | |
| Biomarin Pharmaceutical INC. | $34.42 | 2023 | Brineura |
| Neurelis, INC. | $34.41 | 2023 | Valtoco |
| Immedica Pharma US, INC. | $28.95 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.61 | 2025 | Vpriv |
| Phadia US INC. | $17.00 | 2024 | Immunocap |
| Jazz Pharmaceuticals INC. | $16.84 | 2023 | |
| Corium, LLC | $13.98 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Mcgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.